|
Volumn 7, Issue 12, 2011, Pages 5873-5878
|
An in situ-forming, solid lipid/PLGA hybrid implant for long-acting antipsychotics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BURST RELEASE;
CONTROLLED RELEASE;
DELIVERY SYSTEMS;
DRUG CONCENTRATION;
DRUG DELIVERY SYSTEM;
DRUG RELEASE;
EFFECTIVE SOLUTION;
GLYCERYL MONOSTEARATE;
HYBRID SOLIDS;
IN-SITU;
IN-VITRO;
IN-VIVO;
INJECTABILITY;
INTRAMUSCULAR INJECTIONS;
MEAN RESIDENCE TIME;
PHASE INVERSION;
RISPERIDONE;
SURGICAL OPERATION;
SUSTAINED DRUG RELEASE;
BIOCHEMISTRY;
BIODEGRADATION;
DISPLAY DEVICES;
DRUG DELIVERY;
DRUG PRODUCTS;
HYBRID SYSTEMS;
STEARIC ACID;
SURGERY;
IMPLANTS (SURGICAL);
|
EID: 79959226051
PISSN: 1744683X
EISSN: 17446848
Source Type: Journal
DOI: 10.1039/c1sm05310h Document Type: Article |
Times cited : (25)
|
References (33)
|